Nuclear Radiology: Page 22

German team casts doubt on PET's value in Alzheimer's

By Wayne Forrest

Researchers from a leading German facility have investigated whether a person's progression from mild cognitive impairment to Alzheimer's disease can be reliably predicted without PET imaging. Their study published online on 18 October in the Journal of Nuclear Medicine lists several nonimaging methods that can offer a better prognosis than the modality.

October 30, 2019

ICSCNM updates molecular radiotherapy guidance

By AuntMinnieEurope.com staff writers

The Intercollegiate Standing Committee on Nuclear Medicine (ICSCNM) has released the second edition of its guidance for clinicians on molecular radiotherapy.

October 29, 2019

RCR finds radioisotope import plan 'reassuring'

By AuntMinnieEurope.com staff writers

The U.K. Royal College of Radiologists (RCR) said the Department of Health and Social Care has confirmed that as of 21 October, all imported radioisotopes destined for U.K. hospitals should be entering the U.K. by air.

October 29, 2019

MR Solutions shows new PET/CT units at EANM 2019

By AuntMinnieEurope.com staff writers

Preclinical imaging technology developer MR Solutions showcased a line of preclinical PET/CT systems at the recent European Association of Nuclear Medicine (EANM) annual meeting in Barcelona, Spain.

October 22, 2019

Hermes gets FDA clearance for radiation dose software

By AuntMinnieEurope.com staff writers

Hermes Medical Solutions has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Voxel Dosimetry software for estimating radiation dose in nuclear medicine studies.

October 22, 2019

Nordion explores Romanian partnership

By AuntMinnieEurope.com staff writers

Radioisotope firm Nordion has signed an agreement with Societatea Nationala Nuclearelectrica of Romania to explore the potential commercial production of cobalt-60 at the Cernavodă Nuclear Power Plant.

October 9, 2019

Sofie signs deal with ABX for cGMP compliance

By AuntMinnieEurope.com staff writers

Molecular imaging developer Sofie Biosciences has signed an agreement with ABX Advanced Biochemical Compounds of Radeberg, Germany, for ABX to provide Sofie with current good manufacturing practice (cGMP) precursor and reference standards for Sophie's fibroblast activation protein inhibitor compounds.

October 9, 2019

GE, Theragnostics partner on PSMA agent

By AuntMinnieEurope.com staff writers

GE Healthcare and Theragnostics have signed a global partnership to develop a new prostate-specific membrane antigen (PSMA) PET/CT imaging agent.

October 8, 2019

ITM, Bruce Power complete feasibility study

By AuntMinnieEurope.com staff writers

German radiopharmaceutical group ITM Isotopen Technologien München and Canadian isotope supplier Bruce Power have completed a joint feasibility study for the irradiation of ytterbium-176 to produce lutetium-177.

October 1, 2019

GE and partners to develop PET tracers

By AuntMinnieEurope.com staff writers

GE Healthcare is teaming up with three companies and one U.S. academic institution to develop a portfolio of PET tracers designed to better predict and monitor patient response to immunotherapies.

September 24, 2019

Affibody, GE to collaborate on PET tracers

By AuntMinnieEurope.com staff writers

Biopharmaceutical company Affibody and GE Healthcare are collaborating to develop and bring to market Affibody's PET imaging tracers.

September 19, 2019

Swiss cast new light on prostate cancer analysis

By Wayne Forrest

Researchers from Zurich have found gallium-68 prostate-specific membrane antigen offers better sensitivity, while multiparametric MRI provides better specificity, especially when determining tumor cell spread beyond the lymph node capsule or when prostate cancer extends into the seminal vesicles.

September 15, 2019

Previous Page

Page 22 of 90

Next Page